Dual bronchodilation for the treatment of COPD: from bench to bedside
M Cazzola, C Page, P Rogliani… - British Journal of …, 2022 - Wiley Online Library
Because there is a solid pharmacological rationale based on positive interactions between
long‐acting muscarinic receptor antagonists (LAMAs) and long‐acting β‐agonists (LABAs) …
long‐acting muscarinic receptor antagonists (LAMAs) and long‐acting β‐agonists (LABAs) …
[HTML][HTML] Gold nanoparticle-based colorimetric and electrochemical sensors for the detection of illegal food additives
L Li, M Zhang, W Chen - Journal of Food and Drug Analysis, 2020 - ncbi.nlm.nih.gov
Lately, scandals associated with the illegal addition of poisonous chemicals to food for
commercial interests have been gradually disclosed to the public. Problems related to food …
commercial interests have been gradually disclosed to the public. Problems related to food …
Effects of ivabradine on right ventricular systolic function in patients with chronic obstructive pulmonary disease and cor pulmonale
R Rossi, F Coppi, FA Sgura, DE Monopoli… - The American Journal of …, 2023 - Elsevier
Cor pulmonale is a clinical syndrome associated with pulmonary hypertension, frequently
complicated by congestive heart failure, commonly caused by chronic obstructive pulmonary …
complicated by congestive heart failure, commonly caused by chronic obstructive pulmonary …
Chronic bronchial infection and incident cardiovascular events in chronic obstructive pulmonary disease patients: A long‐term observational study
Background and objective Cardiovascular (CV) diseases are frequent in patients with
chronic obstructive pulmonary disease (COPD). Likewise, chronic bronchial infection (CBI) …
chronic obstructive pulmonary disease (COPD). Likewise, chronic bronchial infection (CBI) …
Cardiovascular events and all‐cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long‐acting beta2‐agonists
C Rebordosa, DK Farkas, J Montonen… - … and Drug Safety, 2022 - Wiley Online Library
Purpose We examined the effect of olodaterol on the risk of myocardial ischaemia, cardiac
arrhythmia, and all‐cause mortality compared with use of other long‐acting beta2‐agonists …
arrhythmia, and all‐cause mortality compared with use of other long‐acting beta2‐agonists …
Comparison of clinical outcomes among different fixed-dose combinations of long-acting muscarinic antagonists and long-acting β2-agonists in patients with COPD
CF Weng, CC Wu, MH Wu, FJ Lin - Chest, 2023 - Elsevier
Background Researchers have yet to obtain conclusive evidence differentiating among fixed-
dose combinations (FDCs) of long-acting muscarinic antagonists (LAMAs) and long-acting β …
dose combinations (FDCs) of long-acting muscarinic antagonists (LAMAs) and long-acting β …
[HTML][HTML] Efficacy of acupuncture as an adjunctive treatment to patients with stable COPD: a multicenter, randomized, sham-controlled trial protocol
L Huang, S Yang, G Xu, Q Luo, C Yang, H Tian… - … Medicine and Therapies, 2024 - Springer
Background Chronic obstructive pulmonary disease (COPD) is a common respiratory
disease and the third leading cause of death worldwide. Previous evidence has shown that …
disease and the third leading cause of death worldwide. Previous evidence has shown that …
Use of prescription medications with cardiovascular adverse effects among older adults in the United States
K Ozenberger, GC Alexander, JI Shin… - … and Drug Safety, 2022 - Wiley Online Library
Background Many commonly used prescription medications have cardiovascular adverse
effects, yet the cumulative risk of cardiovascular events associated with the concurrent use of …
effects, yet the cumulative risk of cardiovascular events associated with the concurrent use of …
[HTML][HTML] Evolving treatment for prematurity-associated lung disease
CW Course, SJ Kotecha, S Kotecha - Translational Pediatrics, 2024 - ncbi.nlm.nih.gov
Evolving treatment for prematurity-associated lung disease - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …
Development and validation of LC-MS/MS methods for the quantification of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, and its …
H Gao, M Cheng, H Liu, L Ding - Journal of Pharmaceutical and Biomedical …, 2023 - Elsevier
Abstract 101BHG-D01 is a novel, long-acting and selective muscarinic receptor antagonist
for the treatment of chronic obstructive pulmonary disease (COPD) and rhinorrhea in rhinitis …
for the treatment of chronic obstructive pulmonary disease (COPD) and rhinorrhea in rhinitis …